Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 876.00
Bid: 848.00
Ask: 876.00
Change: 48.00 (5.80%)
Spread: 28.00 (3.302%)
Open: 840.00
High: 876.00
Low: 822.00
Prev. Close: 828.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of secondary placing of existing shares

27 Apr 2016 10:26

RNS Number : 5050W
Mortgage Advice Bureau(Holdings)PLC
27 April 2016
 

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

 

Not for publication, distribution or release directly or indirectly, in whole or in part, into or in the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States"), Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction in which offers for sale would be prohibited by applicable law.

 

This announcement is not an offer to sell or a solicitation to buy securities in any jurisdiction, including the United States, Australia, Canada, Japan or the Republic of South Africa. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

 

27 April 2016 

 

Result of secondary placing of existing ordinary shares in MAB

 

On 27 April 2016, MAB announced that it had been advised by certain individual shareholders (and some of their respective spouses and SIPPs) of the Company (the "Selling Shareholders"), including certain board directors of the Company, of their intention to sell up to 7,569,240 ordinary shares in the Company (the "Placing Shares") via an accelerated bookbuild to institutional investors (the "Placing").

 

MAB announces that the Selling Shareholders have subsequently sold 7,569,240 ordinary shares in the Company, representing approximately 15.0% per cent of the Company's issued share capital. The Placing Shares were placed at a price of 360 pence per share and were sold to institutional investors in a placing managed by Canaccord Genuity Limited and Zeus Capital Limited.

 

Details of the number of Placing Shares sold by the Selling Shareholders are as follows:

 

 

 

Shareholding pre-placing(1)

Number of Placing Shares sold

Resultant holding(1)

Selling shareholder

Number of ordinary shares

Percentage of issued share capital

 

Number of ordinary shares

Percentage of issued share capital

Peter Brodnicki(2)

18,126,400

35.92

4,015,490

14,110,910

27.96

David Preece(3)

2,574,800

5.10

1,050,000

1,524,800

3.02

Paul Robinson(4)

2,574,400

5.10

1,500,000

774,400

1.53

Michelle Draycott

1,365,000

2.71

341,250

1,023,750

2.03

Simon Blunt

845,000

1.67

211,250

633,750

1.26

Richard Palmer

844,000

1.67

211,000

633,000

1.25

Gareth Herbert

557,000

1.10

105,750

451,250

0.89

Simon A Frankish

538,000

1.07

134,500

403,500

0.80

       

 

(1) Including those shares held by members of the shareholder's family as defined in the AIM Rules for Companies and those held in the Company's Share Incentive Plan.

(2) Peter Brodnicki also holds options over 325,000 ordinary shares.

(3) David Preece also holds options over 275,000 ordinary shares.

(4) Concurrently with completion of the Placing, Paul Robinson has gifted for nil consideration 300,000 ordinary shares in the Company to a third party who does not constitute a family member for the purposes of the AIM Rules and Paul Robinson therefore no longer has any disclosable interest in those ordinary shares.

 

Following the Placing, the members of the Concert Party (as defined in the Company's Admission Document) excluding Michelle Draycott, who as announced by the Company earlier today is no longer considered to be acting in concert with Peter Brodnicki, David Preece and Paul Robinson, have a combined interest of 16,410,110 ordinary shares in the Company, representing 32.52 per cent of the Company's issued share capital.

 

Enquiries:

 

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

 

 Zeus Capital +44 (0)20 3829 5000

Martin Green

Nicholas How

Pippa Underwood

 

Canaccord Genuity +44 (0)20 7523 8350

Roger Lambert

Kit Stephenson

Richard Andrews

 

Media Enquiries: 

investorrelations@mab.org.uk 

 

 

 

MEMBERS OF THE GENERAL PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES ARE ONLY ADDRESSED TO AND DIRECTED AT (1) IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(1)(E) OF EU DIRECTIVE 2003/71/EC AND ANY RELEVANT IMPLEMENTING MEASURES (THE "PROSPECTUS DIRECTIVE"); AND (2) IN THE UNITED KINGDOM, PERSONS WHO (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) (THE "ORDER"); OR (II) FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER; OR (III) ARE PERSONS TO WHOM AN OFFER OF THE PLACING SHARES MAY OTHERWISE LAWFULLY BE MADE (ALL SUCH PERSONS REFERRED TO IN (1) AND (2) TOGETHER BEING REFERRED TO AS "RELEVANT PERSONS"). THE INFORMATION REGARDING THE PLACING SET OUT IN THIS ANNOUNCEMENT MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

 

 

These materials do not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. Securities may not be offered or sold in the United States absent (i) registration under the U.S. Securities Act of 1933, as amended (the "Securities Act") or (ii) an available exemption from registration under the Securities Act. The Placing Shares may not be offered or sold in the United States unless registered under the Securities Act or offered in a private transaction exempt from, or not subject to, the registration requirements of the US Securities Act and the securities laws of any relevant state or other jurisdiction of the United States. The Placing Shares will not be offered to the public in the United States.

 

This announcement and the information contained herein is for information purposes only and does not constitute or form part of any offer of, or the solicitation of an offer to acquire or dispose of securities in Australia, Canada, Japan, the Republic of South Africa or in any other jurisdiction in which such an offer or solicitation is unlawful.

 

The Placing Shares have not been, and will not be, registered under the applicable securities laws of any state or other jurisdiction of Australia, Canada, Japan or the Republic of South Africa. There will be no public offering of the Placing Shares in Australia, Canada, Japan or the Republic of South Africa or elsewhere.

 

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by the Selling Shareholders or Zeus Capital Limited or any of their respective affiliates.

 

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in or into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Japan or the Republic of South Africa. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws.

 

The distribution of this announcement and the offering or sale of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Selling Shareholders, Zeus Capital Limited, or Canaccord Genuity Limited or any of their respective affiliates that would, or which is intended to, permit a public offer of the Placing Shares in any jurisdiction or possession or distribution of this announcement or any other offering or publicity material relating to the Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Selling Shareholders, Zeus Capital Limited and Canaccord Genuity Limited to inform them about and to observe any applicable restrictions.

 

Zeus Capital Limited and Canaccord Genuity Limited, who are regulated by the Financial Conduct Authority in the United Kingdom, are acting exclusively on behalf of the Selling Shareholders and no one else in connection with any offering of the Placing Shares and will not be responsible to anyone other than the Selling Shareholders for providing the protections offered to the clients of Zeus Capital Limited and Canaccord Genuity Limited, nor for providing advice in relation to the Placing or any matters referred to in this announcement.

 

This announcement has been issued by, and is the sole responsibility of, the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Zeus Capital Limited or Canaccord Genuity Limited or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers, and any liability therefore is expressly disclaimed.

 

This document includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. Any forward-looking statements are subject to risks relating to future events and assumptions relating to MAB's business, in particular from changes in political conditions, economic conditions, evolving business strategy, or the mortgage intermediary industry. No assurances can be given that the forward-looking statements in this document will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual results or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKDLBLQZFLBBX
Date   Source Headline
10th May 20247:00 amRNSNotification of Major Holdings
1st May 20247:00 amRNSNotification of Major Holdings
30th Apr 20242:21 pmRNSDirectors' Shareholdings and PDMR notification
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.